NIH-funded research R01 grant

Virtual PEth-based Contingency Management for Adults with Alcohol Use Disorder

Official title: Assessing the Clinical and Cost-Effectiveness of a Virtual PEth-based Contingency Management for Adults with AUD

Funded at Washington State University · NIH-11396448 · Data updated 2026-11-12

A telehealth program uses a blood marker and rewards to help adults stay abstinent from alcohol over about six months.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington State University
NIH-funded
Lab location1 site (Pullman, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$687,476
NIH project number5R01AA031013-04
Project IDNIH-11396448 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 and older with alcohol use disorder who can participate in telehealth visits and provide periodic biomarker samples.

Less likely to help

Individuals unable to comply with remote monitoring or who require in-person interventions for safety or other medical reasons.

What this research studies

This project tests a telehealth contingency management approach that uses PEth, a blood biomarker, to verify abstinence over a 26-week period. Participants receive tangible rewards for submitting samples that show no alcohol use, delivered remotely to make care convenient. The study aims to reduce barriers like stigma, travel, and frequent in-person visits by leveraging telehealth and a simple biomarker. If successful, it could offer a feasible, longer-lasting support option for adults with alcohol use disorder.

Why it matters

Potential benefit: If successful, patients could experience longer, more accessible support to stay abstinent from alcohol between treatment and follow-up.

How similar studies have gone: Prior telehealth CM studies show reductions in alcohol use, with PEth-based approaches offering a longer detection window and feasibility.

Where this research is happening

  • Washington State University
    Pullman, United States
    Active

Researchers

  • Principal investigator: Mcdonell, Michael G — Washington State University
  • Study coordinator: Mcdonell, Michael G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.